T1	total-participants 165 177	Four hundred
T2	age 204 218	under 70 years
T3	eligibility 219 267	diagnosed with a clinical T1 or T2 breast cancer
T4	intervention 295 322	post-operative radiotherapy
T5	intervention 328 331	208
T6	control 336 339	not
T7	control-participants 345 348	192
T10	outcome 749 772	local breast recurrence
T11	iv-bin-percent 778 783	28.6%
T12	cv-bin-percent 851 856	49.8%
T13	outcome 956 988	disease-free or overall survival
T14	outcome 994 1016	hazard ratio for death
T8	intervention 77 119	irradiation following conservative surgery
T15	outcome 1202 1225	locoregional recurrence
T16	outcome 1282 1313	incidence of distant metastases
T17	outcome 1317 1330	time of death
T18	outcome 1406 1424	distant recurrence
T19	outcome 1495 1513	distant recurrence
